Clinical Trials Directory

Trials / Completed

CompletedNCT04892238

Helicobacter Pylori Infection Occurrence in Russia

Helicobacter Pylori Infection Occurrence in Primary Care Settings in Russia

Status
Completed
Phase
Study type
Observational
Enrollment
70,000 (actual)
Sponsor
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Accepted

Summary

This study is planned to reveal the occurrence rate of H.pylori infection in ambulatory settings' patients in Russia and to compare the occurrence rates in different years in treatment-naïve and previously treated subjects.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST13-C urea breath testStandard urea breath test (UBT) ("HELICARB", LLC "ISOCARB", reg. cert. #РЗН 2016/3773 issued by Roszdravnadzor on 29.02.2016) with 13C-carbamide of 99% purity used for the study. Samples of exhaled air obtained before and after 20 minutes after 50 mg 13C-urea intake are analysed for 13C/12C isotope ratio with the use of infrared spectrometer "IRIS.Doc" (Kibion, Sweden). Delta over baseline (δ) of 13C / 12C is calculated based on the results of the initial and second samples, the results were shown in ppm (‰). The results of the test is negative if δ was \<4.0‰; test results with δ ≥4.0‰ are considered positive.

Timeline

Start date
2017-01-01
Primary completion
2019-12-31
Completion
2020-07-31
First posted
2021-05-19
Last updated
2021-05-19

Locations

2 sites across 1 country: Russia

Source: ClinicalTrials.gov record NCT04892238. Inclusion in this directory is not an endorsement.